Abstract
Purpose
Several meta-analyses and systematic reviews have reported data about the prevalence and the malignancy risk of focal incidental uptake detected by 18F-FDG PET (FIU). This review aims to summarize the published evidence-based data about the most common sites, prevalence and malignancy risk of FIU, to derive schematic estimates in this setting.
Methods
A comprehensive computer literature search of meta-analyses or systematic reviews regarding FIU and published in PubMed/MEDLINE and/or Cochrane library database through June 2017 was carried out.
Results
Twelve articles were discussed in our summary and different organs were evaluated. The pooled prevalence of FIU ranged, respectively, from 1.6 to 3.6% for colon–rectum, from 1 to 2.46% for thyroid, being 0.4% for breast, 1.8% for prostate and 0.6% for parotid. Despite that, the pooled risk of malignancy considering histology as reference standard was quite high in all organs evaluated in the summary, except for parotid gland. In fact, it ranged from 61.5 to 76% for FIU in the colon–rectum (including both premalignant and malignant lesions), from 33.2 to 37% for FIU in the thyroid gland, and it was 60 and 62%, respectively, for breast and prostate FIU. For parotid FIU pathologically proven the pooled risk of malignancy was only 20.4%.
Conclusions
Our summary showed that the most frequent sites of FIUs are colon and thyroid according to literature data. The risk of malignancy is quite high for FIU in colon-rectum, thyroid, breast and prostate especially when histologically analyzed. Beyond the localization, when FIU are detected further investigation is warranted.
Similar content being viewed by others
References
Lumbreras B, Donat L, Hernandez-Aguado I (2010) Incidental findings in imaging diagnostic tests: a systematic review. Br J Radiol 83:276–289
Kapoor A, Morris T, Rebello R (2011) Guidelines for the management of the incidentally discovered adrenal mass. Can Urol Assoc J 5:241–247
Corrigan AJ, Schleyer PJ, Cook GJ (2015) Pitfalls and artifacts in the use of PET/CT in oncology imaging. Semin Nucl Med 45:481–499
Ballinger JR (2015) Pitfalls and limitations of SPECT, PET, and therapeutic radiopharmaceuticals. Semin Nucl Med 45:470–478
Bertagna F, Treglia G, Piccardo A, Giovannini E, Bosio G, Biasiotto G, el Bahij K, Maroldi R, Giubbini R (2013) FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centers on the significance of focal uptake and SUV value. Endocrine 43:678–685
Gill RS, Perry T, Abele JT, Bédard EL, Schiller D (2012) The clinical significance of incidental intra-abdominal findings on positron emission tomography performed to investigate pulmonary nodules. World J Surg Oncol 10:25
Magee AL, Dashevsky BZ, Jahangir K, Kulkarni K (2017) Incidental focal uptake in the breast and axilla on FDG PET: clinical considerations and differential diagnosis. Clin Imaging 45:96–104
Treglia G, Calcagni ML, Rufini V, Leccisotti L, Meduri GM, Spitilli MG, Dambra DP, De Gaetano AM, Giordano A (2012) Clinical significance of incidental focal colorectal 18F-fluoro- deoxyglucose uptake: our experience and a review of the literature. Colorectal Dis 14:174–180
Basu S, Houseni M, Alavi A (2008) Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management. Nucl Med Commun 29:367–373
Han EJ, Ho J, Choi WH, Yoo IR, Chung SK (2010) Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images. Br J Radiol 83:915–920
Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, Fischer D (2005) PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 46:758–762
Grassi I, Castellucci P, Nanni C, Ghedini P, Ambrosini V, Allegri V, Montini GC, Guidalotti PL, Fanti S (2014) Incidentally detected increased FDG uptake in bowel and its correlation with hystopathological data: our experience in a case series study. Curr Radiopharm 7:107–114
Agrawal K, Weaver J, Ngu R, Krishnamurthy Mohan H (2015) Clinical significance of patterns of incidental thyroid uptake at (18)F-FDG PET/CT. Clin Radiol 70:536–543
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006–1012
Sadeghi R, Treglia G (2017) Systematic reviews and meta-analyses of diagnostic studies: a practical guideline. Clin Transl Imaging 5:83–87
Treglia G, Bertagna F, Sadeghi R, Verburg FA, Ceriani L, Giovanella L (2013) Focal thyroid incidental uptake detected by 18F-Fluorodeoxyglucose positron emission tomography: meta-analysis on prevalence and malignancy risk. Nuklearmedizin 52:130–136
Qu N, Zhang L, Lu ZW, Wei WJ, Zhang Y, Ji QH (2014) Risk of malignancy in focal thyroid lesions identified by (18) F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography: evidence from a large series of studies. Tumour Biol 35:6139–6147
Nayan S, Ramakrishna J, Gupta MK (2014) The proportion of malignancy in incidental thyroid lesions on 18-FDG PET study: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 151:190–200
Shie P, Cardarelli R, Sprawls K, Fulda KG, Taur A (2009) Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun 30:742–748
Bertagna F, Treglia G, Piccardo A, Giubbini R (2012) Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab 97:3866–3875
Soelberg KK, Bonnema SJ, Brix TH, Hegedus L (2012) Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 22:918–925
Treglia G, Taralli S, Salsano M, Muoio B, Sadeghi R, Giovanella L (2014) Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18)F-FDG-PET or PET/CT: a meta-analysis. Radiol Oncol 48:99–104
Shie P (2011) Incidental focal hypermetabolic colorectal lesions identified by positron emission tomography: prevalence of malignancy. Abdom Imaging 36:165–169
Kousgaard SJ, Thorlacius-Ussing O (2017) Incidental colorectal FDG uptake on PET/CT scan and lesions observed during subsequent colonoscopy: a systematic review. Tech Coloproctol. doi:10.1007/s10151-017-1652-6
Bertagna F, Treglia G, Orlando E, Dognini L, Giovanella L, Sadeghi R, Giubbini R (2014) Prevalence and clinical significance of incidental F18-FDG breast uptake: a systematic review and meta-analysis. Jpn J Radiol 32:59–68
Bertagna F, Sadeghi R, Giovanella L, Treglia G (2014) Incidental uptake of 18F-fluorodeoxyglucose in the prostate gland. Systematic review and meta-analysis on prevalence and risk of malignancy. Nuklearmedizin 53:249–258
Treglia G, Bertagna F, Sadeghi R, Muoio B, Giovanella L (2015) Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis. Eur Arch Otorhinolaryngol 272:3617–3626
Ooh SH, Jung SA, Kim SE, Kim HI, Lee MJ, Tae CH et al (2012) The clinical meaning of benign colon uptake in 18 FDG PET: comparison with Colonscopic findings. Clin Endosc 45:145–150
Tatlidil R, Jadvar H, Bading JR, Conti PS (2002) Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 224:783–787
Isobe K, Hata Y, Sakaguchi S, Takai Y, Shibuya K, Takagi K et al (2010) The role of positron emission tomography in the detection of incidental gastrointestinal tract lesions in patients examined for lung cancer. Nihon Kokyuki Gakkai Zasshi 48:482–487
Chopra A, Ford A, De Noronha R, Matthews S (2012) Incidental findings on positron emission tomography/CT scans performed in the investigation of lung cancer. Br J Radiol 85:e229–e237
van Hoeij FB, Keijsers RG, Loffeld BC, Dun G, Stadhouders PH, Weusten BL (2015) Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy? Eur J Nucl Med Mol Imaging 42:66–71
Seivert M, Plomteux O, Colard A, Leclercq P, Gauthier D, Houbiers G et al (2014) Endoscopic findings in case of incidental colonic uptake in PET-CT how to improve PET-CT specificity? Acta Gastroenterol Belg 77:413–417
Jin J, McHenry CR (2012) Thyroid incidentaloma. Best Pract Res Clin Endocrinol Metab 26:83–96
Yasuda S, Shohtsu A, Ide M, Takagi S, Takahashi W, Suzuki Y et al (1998) Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 207:775–778
Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H (1998) Glucose metabolism of the thyroid in Graves’s disease measured by F-18-fluoro-deoxyglucose positron emission tomography. Thyroid 8:765–772
Kroiss A, Uprimny C, Virgolini IJ (2016) Thyroid carcinoma detected by incidental (18)F-FDG uptake in a patient with progressive cerebellar syndrome. Endocrine 51:199–200
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133
Yang Z, Hu S, Cheng J, Xu J, Shi W, Zhu B et al (2014) Prevalence and risk of cancer of incidental uptake in prostate identified by fluorine-18fluorodeoxyglucose positron emission tomography/computed tomography. Clin Imaging 38:470–474
Bhosale P, Balachandran A, Vikram R, Viswanathan C, Macapinlac H, Rohren E et al (2013) What is the clinical significance of FDG unexpected uptake in the prostate in patients undergoing PET/CT for other malignancies? Int J Mol Imaging 2013:476–786
Cho SK, Choi JY, Yoo J, Cheon M, Lee JY, Hyun SH et al (2011) Incidental focal 18F-FDG uptake in the prostate: clinical significance and differential diagnostic criteria. Nucl Med Mol Imaging 45:192–196
Basu S, Houseni M, Alavi A (2008) Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management. Nucl Med Commun 29:367–373
Sreeja C, Shahela T, Aesha S, Satish MK (2014) Taxonomy of salivary gland neoplasm. J Clin Diagn Res 8:291–293
Bertagna F, Nicolai P, Maroldi R, Mattavelli D, Bertoli M, Giubbini R et al (2015) Diagnostic role of (18)F-FDG-PET or PET/CT in salivary gland tumors: a systematic review. Rev Esp Med Nucl Imagen Mol 34:295–302
Toriihara A, Nakamura S, Kubota K, Makino T, Okochi K, Shibuya H (2013) Can dual-time-point 18F-FDG PET/CT differentiate malignant salivary gland tumors from benign tumors? AJR Am J Roentgenol 201:639–644
Acknowledgements
All authors have made substantial contributions to all of the following: (1) the conception and design of the study, acquisition of data, analysis and interpretation of data, (2) drafting and revising the article; (3) final approval of the submitted version.
Author information
Authors and Affiliations
Contributions
A Tamburello: literature search and review, content planning and manuscript writing. G. Treglia: literature search and review, manuscript writing and language editing. D. Albano: manuscript editing. F. Bertagna:manuscript editing. L. Giovanella: manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
All authors (Adriana Tamburello, Giorgio Treglia, Domenico Albano, Francesco Bertagna and Luca Giovanella) declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Adriana Tamburello and Giorgio Treglia share the first authorship.
Rights and permissions
About this article
Cite this article
Tamburello, A., Treglia, G., Albano, D. et al. Prevalence and clinical significance of focal incidental 18F-FDG uptake in different organs: an evidence-based summary. Clin Transl Imaging 5, 525–532 (2017). https://doi.org/10.1007/s40336-017-0253-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40336-017-0253-8